Artiva shuts down cell therapy after two patient deaths in trial

Reuters, the San Diego Union-Tribune and STAT report that Artiva is discontinuing its autoimmune cell therapy after two patient deaths, with workforce cut by 94%. Items describe the layoffs as following a trial failure.

Timeline

1. 28 Oct, 11:50 UTCFirst appeared on Google Trends
2. 28 Oct, 11:50 UTCReuters reports discontinuation and 94% workforce cut
3. 28 Oct, 11:50 UTCSTAT covers shutdown after two trial deaths

Top sources

• artivaGoogle Trends
• Artiva to discontinue cell therapy after two patient deaths, cut workforce by 94%Reuters
• San Diego biotech lays off nearly all its staff after drug trial failure and 2 patient deathsSan Diego Union-Tribune